76 related articles for article (PubMed ID: 1458009)
1. Therapeutic use of insulin-like growth factor I: lessons from in vivo animal studies.
Gluckman PD; Ambler GR
Acta Paediatr Suppl; 1992 Sep; 383():134-6. PubMed ID: 1458009
[No Abstract] [Full Text] [Related]
2. The chronicle of growth hormone receptor deficiency (Laron syndrome).
Rosenbloom AL
Acta Paediatr Suppl; 1992 Sep; 383():117-20. PubMed ID: 1458005
[No Abstract] [Full Text] [Related]
3. [Human insulin-like growth factor I and treatment in diabetes].
Koivisto VA
Duodecim; 1994; 110(23-24):2197-201. PubMed ID: 8654239
[No Abstract] [Full Text] [Related]
4. Effects of recombinant insulin-like growth factor I on IGF binding proteins and the acid-labile subunit in growth hormone insensitivity syndrome.
Walker JL; Baxter RC; Young S; Pucilowska J; Clemmons DR; Underwood LE
Growth Regul; 1993 Mar; 3(1):109-12. PubMed ID: 7683514
[No Abstract] [Full Text] [Related]
5. Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism).
Walker JL; Ginalska-Malinowska M; Romer TE; Pucilowska JB; Underwood LE
N Engl J Med; 1991 May; 324(21):1483-8. PubMed ID: 2023608
[No Abstract] [Full Text] [Related]
6. An update on Laron syndrome.
Laron Z
Arch Dis Child; 1993 Mar; 68(3):345-6. PubMed ID: 8466235
[No Abstract] [Full Text] [Related]
7. Tissue-specific alterations in insulin-like growth factor-I concentrations in response to 3,3',5-triiodo-L-thyronine supplementation in the growth hormone receptor-deficient sex-linked dwarf chicken.
Vasilatos-Younken R; Dunnington EA; Siegel PB; McMurtry JP
Gen Comp Endocrinol; 1997 Jan; 105(1):31-9. PubMed ID: 9000465
[TBL] [Abstract][Full Text] [Related]
8. Disorders of growth hormone resistance in childhood.
Laron Z
Curr Opin Pediatr; 1993 Aug; 5(4):474-80. PubMed ID: 8374676
[TBL] [Abstract][Full Text] [Related]
9. Although both rhGh and rhIGF-I have the potential to provide clinical benefit, each also has the potential to produce unwanted side-effects.
Le Roith D
Growth Horm IGF Res; 1999 Apr; 9(2):83. PubMed ID: 10373340
[No Abstract] [Full Text] [Related]
10. [The role of the GH/IGF-1 axis in cardiovascular physiopathology and therapy: the lessons from animal studies].
Cittadini A; Durante Mangoni E; Palmieri EA; Casaburi C; Longobardi S; Di Rella F; Fazio S; Saccà L
Cardiologia; 1998 Nov; 43(11):1185-92. PubMed ID: 9922584
[No Abstract] [Full Text] [Related]
11. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models.
Yakar S; Leroith D; Brodt P
Cytokine Growth Factor Rev; 2005; 16(4-5):407-20. PubMed ID: 15886048
[TBL] [Abstract][Full Text] [Related]
12. [From research of non-suppressible serum insulin activity to the clinical application of recombinant insulin-like growth factor (rhIGF-I)].
Froesch ER
Schweiz Med Wochenschr; 1995 Jul; 125(27-28):1326-35. PubMed ID: 7624742
[TBL] [Abstract][Full Text] [Related]
13. Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome.
Quin JD; Fisher BM; Paterson KR; Inoue A; Beastall GH; MacCuish AC
N Engl J Med; 1990 Nov; 323(20):1425-6. PubMed ID: 2233914
[No Abstract] [Full Text] [Related]
14. Growth hormone and insulin-like growth factor-I: effects on the growth of glioma cell lines.
Friend KE; Khandwala HM; Flyvbjerg A; Hill H; Li J; McCutcheon IE
Growth Horm IGF Res; 2001 Apr; 11(2):84-91. PubMed ID: 11472074
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone insensitivity syndrome (Laron syndrome): main characteristics and effects of IGF1 treatment.
Carel JC; Chaussain JL; Chatelain P; Savage MO
Diabetes Metab; 1996 Jul; 22(4):251-6. PubMed ID: 8767171
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone and insulin-like growth factor-I in odontogenesis.
Young WG
Int J Dev Biol; 1995 Feb; 39(1):263-72. PubMed ID: 7626416
[TBL] [Abstract][Full Text] [Related]
17. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders.
Savage MO; Attie KM; David A; Metherell LA; Clark AJ; Camacho-Hübner C
Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):395-407. PubMed ID: 16932322
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and therapeutic advances in growth hormone insensitivity.
David A; Metherell LA; Clark AJ; Camacho-Hübner C; Savage MO
Endocrinol Metab Clin North Am; 2005 Sep; 34(3):581-95, viii. PubMed ID: 16085161
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor type-1 receptor down-regulation associated with dwarfism in Holstein calves.
Blum JW; Elsasser TH; Greger DL; Wittenberg S; de Vries F; Distl O
Domest Anim Endocrinol; 2007 Oct; 33(3):245-68. PubMed ID: 16829014
[TBL] [Abstract][Full Text] [Related]
20. Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism.
Laron Z; Klinger B; Erster B; Anin S
Lancet; 1988 Nov; 2(8621):1170-2. PubMed ID: 2903379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
